These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials]. Schillaci G; Vaudo G Ital Heart J Suppl; 2001 Jul; 2(7):799-802. PubMed ID: 11508301 [No Abstract] [Full Text] [Related]
11. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension. Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095 [TBL] [Abstract][Full Text] [Related]
12. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [TBL] [Abstract][Full Text] [Related]
13. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine? Burnier M; Pruijm M; Wuerzner G Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074 [TBL] [Abstract][Full Text] [Related]
14. Combination of alpha-blockers with other antihypertensive drugs. Reddy KS; Prabhakaran D J Assoc Physicians India; 1998; Suppl 1():22-5. PubMed ID: 11229105 [No Abstract] [Full Text] [Related]
15. New and emerging drug treatments for hypertension. Krum H; Pellizzer AM Aust Fam Physician; 1998 Apr; 27(4):235-7, 240-2. PubMed ID: 9581329 [TBL] [Abstract][Full Text] [Related]
16. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research]. Rajzer M; Kawecka-Jaszcz K; Wojciechowska W Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function. Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
20. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril. Middeke M; Richter WO; Schwandt P; Holzgreve H Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]